The multi-year cannabis sector bear market is starting to give way to a calculated wave of industry consolidation. Behind the urge to merge is a significant shift in U.S. federal regulatory policy, encouraging better-capitalized operators to secure global supply chains before tax relief drives widespread multiple expansion.

Tilray doesn't have appealing growth prospects, despite diversifying into beverages in recent years. It hit record revenue last year, but it was also deeply in the red.

TherapeuticsMD (NASDAQ: TXMD - Get Free Report) and Tilray Brands (NASDAQ: TLRY - Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, valuation, earnings, analyst recommendations and dividends. Volatility and Risk TherapeuticsMD has a beta of

Tilray Brands, Inc. (TSE: TLRY - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Thursday. The company traded as low as C$5.18 and last traded at C$5.18, with a volume of 55663 shares trading hands. The stock had previously closed at C$5.34. Tilray Brands Stock Up 1.0% The stock has

Tilray Brands has consistently underperformed the broader equity market in recent years. Recent industry progress may present lucrative opportunities for the company.

10 Barrel Brewing launches Salty Sips Blackberry Refresher, a low-sugar vodka RTD made with real fruit juice, mint and sea salt, now in select PNW markets.

InterCure (NASDAQ: INCR - Get Free Report) and Tilray Brands (NASDAQ: TLRY - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, profitability, risk, earnings and dividends. Volatility and Risk InterCure has a beta of

The latest trading day saw Tilray Brands, Inc. (TLRY) settling at $4.02, representing a -2.66% change from its previous close.

Tilray's earnings have been volatile in the past due to acquisitions and impairment charges. Although the company's latest quarterly numbers showed improvement, it continues to struggle with consistent growth and profitability.

New appointments strengthen marketing, hospitality, category, and international commercial leadership as BrewDog advances long-term growth under Tilray Brands New appointments strengthen marketing, hospitality, category, and international commercial leadership as BrewDog advances long-term growth under Tilray Brands